"only 10% of people with latent infection convert to active disease"
Alexanders, the problem with this statement is that prior to Cellestis's Quantiferon testing for latent TB has been so inaccurate that figures on latent to active rates are very iffy. With more widespread use of QFT, and therefore a more accurate picture of latent TB, we might find that a greater percentage of people move from latent to active TB.
- Forums
- ASX - By Stock
- Ann: Half Yearly Report and Accounts
CST
castile resources ltd
Add to My Watchlist
3.70%
!
5.6¢

"only 10% of people with latent infection convert to active...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
5.6¢ |
Change
0.002(3.70%) |
Mkt cap ! $17.12M |
Open | High | Low | Value | Volume |
5.4¢ | 5.7¢ | 5.4¢ | $5.316K | 95.38K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 5.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.7¢ | 5789 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.055 |
2 | 37197 | 0.054 |
1 | 199999 | 0.052 |
2 | 59110 | 0.051 |
4 | 151003 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.057 | 5789 | 1 |
0.058 | 279357 | 1 |
0.062 | 99509 | 1 |
0.065 | 54563 | 1 |
0.066 | 8575 | 1 |
Last trade - 15.59pm 18/06/2025 (20 minute delay) ? |
Featured News
CST (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online